Assignee
ACUITAS THERAPEUTICS INC
CA·25 granted patents·20 pending applications·700 citations·filing 2015–2024
Top patents by PatentIndex Score
45 records- 0199US11648324B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·5 cites·6 claims
- 0299US11634379B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·7 cites·25 claims
- 0399US11040112B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 22, 2021·26 cites·34 claims
- 0499US10723692B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·59 cites·34 claims
- 0599US10221127B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·136 cites·51 claims
- 0699US10166298B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Granted Jan 1, 2019·125 cites·39 claims
- 0799US9738593B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2015·Granted Aug 22, 2017·87 cites·47 claims
- 0899US9737619B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 22, 2017·78 cites·27 claims
- 0998US11453639B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·16 cites·23 claims
- 1098US11357856B2Lipids for delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·20 cites·20 claims
- 1198US11168051B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·20 cites·24 claims
- 1298US10106490B2Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2017·Granted Oct 23, 2018·71 cites·19 claims
- 1394US11712481B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2017·Granted Aug 1, 2023·11 cites·35 claims
- 1494US11639329B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted May 2, 2023·6 cites·23 claims
- 1594US11542225B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Jan 3, 2023·8 cites·24 claims
- 1694US11524932B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Dec 13, 2022·8 cites·24 claims
- 1793US11820728B2Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·4 cites·26 claims
- 1892US12065396B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2018·Granted Aug 20, 2024·5 cites·18 claims
- 1992US2025034081A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2091US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
- 2191US11976019B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·4 cites·27 claims
- 2285US2024075163A1Novel lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2381US2025084029A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2480US2024308952A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2579US2025084030A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2672US12410121B2Cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Granted Sep 9, 2025·0 cites·21 claims
- 2772US12151996B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2022·Granted Nov 26, 2024·0 cites·22 claims
- 2872US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2972US2025161227A1Pegylated lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3071US2025188016A1Cationic lipid compounds for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3171US2022204439A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3270US2025236586A1Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3369US2024122854A1Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3467US12491261B2Lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Granted Dec 9, 2025·0 cites·73 claims
- 3565US2024423914A1Amide containing lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3662US2024423915A1Lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3762US2024417370A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3861US2025025427A1Mixed amide ester containing lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3959US2025059131A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4059US2024270679A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4157US2025092002A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4247US2023097090A1Improved lipid nanoparticles for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4346US2019022247A1Lipids and lipid nanoparticle formulations for delivery of nucleic acidsACUITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4438US12583816B2Lipids for lipid nanoparticle delivery of active agentsACUITAS THERAPEUTICS INC·Filed 2019·Granted Mar 24, 2026·0 cites·24 claims
- 4536US12329857B2Systems and methods for manufacturing lipid nanoparticles and liposomesACUITAS THERAPEUTICS INC·Filed 2019·Granted Jun 17, 2025·0 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →